(2021) pilot RCT, older adults receiving GlyNAC for 16 weeks showed significant improvements in cognitive testing, including the Montreal Cognitive Assessment (MoCA) and Digit Symbol Substitution Test [10]
Head-to-head comparisons between arginate and acetate forms in controlled human studies would quantify the bioavailability advantage in clinical terms
However, it still lacks long-term human clinical data on its efficacy and safety profile
This is precisely where the combination with microneedling becomes clinically meaningful, and why we approach GHK-Cu both as an injectable and as a post-needling topical
Despite theoretical fears around cancer risks due to angiogenesis, nobody has reported personal experiences linking this peptide to tumor growth or cancer
These regional differences underline the interplay between population size, lifestyle transitions, and healthcare infrastructure